Investigational Drug Information for Brilacidin
✉ Email this page to a colleague
What is the drug development status for Brilacidin?
Brilacidin is an investigational drug.
There have been 4 clinical trials for Brilacidin.
The most recent clinical trial was a Phase 2 trial, which was initiated on August 14th 2014.
The most common disease conditions in clinical trials are Infections, COVID-19, and Infection. The leading clinical trial sponsors are Innovation Pharmaceuticals, Inc., Cellceutix Corporation, and [disabled in preview].
There are seventeen US patents protecting this investigational drug and four hundred and two international patents.
Summary for Brilacidin
| US Patents | 17 |
| International Patents | 402 |
| US Patent Applications | 58 |
| WIPO Patent Applications | 49 |
| Japanese Patent Applications | 4 |
| Clinical Trial Progress | Phase 2 (2014-08-14) |
| Vendors | 23 |
Recent Clinical Trials for Brilacidin
| Title | Sponsor | Phase |
|---|---|---|
| A Study to Evaluate the Efficacy and Safety of Brilacidin in Hospitalized Participants With COVID-19 | Innovation Pharmaceuticals, Inc. | Phase 2 |
| A Study to Investigate the Use of Delayed Release Tablets for Colonic Delivery of Brilacidin in Healthy Volunteers | Innovation Pharmaceuticals, Inc. | Phase 1 |
| Study of the Effects of Brilacidin Oral Rinse on Radiation-induced Oral Mucositis in Patients With Head and Neck Cancer | Cellceutix Corporation | Phase 2 |
Clinical Trial Summary for Brilacidin
Top disease conditions for Brilacidin
Top clinical trial sponsors for Brilacidin
US Patents for Brilacidin
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Brilacidin | ⤷ Sign Up | Controlled release dosage form | TRIASTEK, INC. (Nanjing, CN) | ⤷ Sign Up |
| Brilacidin | ⤷ Sign Up | Arylamide compounds and compositions and uses thereof | Innovation Pharmaceuticals Inc. (Beverly, MA) | ⤷ Sign Up |
| Brilacidin | ⤷ Sign Up | Aldehyde-tagged immunoglobulin polypeptides and methods of use thereof | Redwood Bioscience, Inc. (Emeryville, CA) | ⤷ Sign Up |
| Brilacidin | ⤷ Sign Up | Hydrazinyl-substituted heteroaryl compounds and methods for producing a conjugate | R.P. Scherer Technologies, LLC (Carson City, NV) | ⤷ Sign Up |
| Brilacidin | ⤷ Sign Up | Pharmaceutical glass packaging assuring pharmaceutical sterility | Corning Incorporated (Corning, NY) | ⤷ Sign Up |
| Brilacidin | ⤷ Sign Up | Compositions and methods for single molecular placement on a substrate | ILLUMINA, INC. (San Diego, CA) | ⤷ Sign Up |
| Brilacidin | ⤷ Sign Up | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients | Corning Incorporated (Corning, NY) | ⤷ Sign Up |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Brilacidin
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Brilacidin | Australia | AU2017261372 | 2036-05-05 | ⤷ Sign Up |
| Brilacidin | Canada | CA3023278 | 2036-05-05 | ⤷ Sign Up |
| Brilacidin | China | CN107847398 | 2036-05-05 | ⤷ Sign Up |
| Brilacidin | European Patent Office | EP3452003 | 2036-05-05 | ⤷ Sign Up |
| Brilacidin | European Patent Office | EP3981392 | 2036-05-05 | ⤷ Sign Up |
| Brilacidin | Hong Kong | HK1249728 | 2036-05-05 | ⤷ Sign Up |
| Brilacidin | Japan | JP2019520866 | 2036-05-05 | ⤷ Sign Up |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
